Isolation of Human Primary Valve Cells for In vitro Disease Modeling
April 16th, 2021
3K views
This protocol describes the collection of human aortic valves extracted during surgical aortic valve replacement procedures or from cadaveric tissue, and the subsequent isolation, expansion, and characterization of patient specific primary valve endothelial and interstitial cells. Included are important details regarding the processes needed to ensure cell viability and phenotype specificity.
Overview
This study outlines a protocol for isolating human primary valve endothelial and interstitial cells from aortic valves obtained during surgical procedures or cadaveric tissue. The findings emphasize methods to enhance cell viability and ensure phenotype specificity, crucial for studying calcific aortic valve disease.
Key Study Components
Research Area
- Cell biology
- Pathogenesis of calcific aortic valve disease
- Tissue engineering
Background
- Calcific aortic valve disease is characterized by alterations in valve morphology.
- Primary valve cells are essential for studying disease mechanisms.
- Maintaining cell viability post-extraction is crucial for successful cell culture.
Methods Used
- Isolation and expansion of valve endothelial and interstitial cells from human tissue.
- Human aortic valves as the biological system.
- Use of collagenase treatment and immunofluorescence for cell characterization.
Main Results
- Methodology ensured approximately 40% cell viability up to 61 hours after extraction.
- Distinct morphologies of endothelial (cobblestone-like) and interstitial cells (spindle-shaped) were observed.
- Both cell types expressed expected tissue-specific markers confirmed through immunostaining.
Conclusions
- The study provides a reliable protocol for deriving valve cells critical for research into valve diseases.
- It contributes valuable insights into methodologies for cell culture in cardiovascular research.
Frequently Asked Questions
What is the importance of isolating valve cells?
Isolating valve cells allows for detailed studies of disease mechanisms and potential therapeutic interventions.
How does the protocol ensure cell viability?
The protocol includes cold storage solutions and specific enzymatic treatments to maintain cell health post-extraction.
What assays were used in this study?
Immunofluorescent staining was utilized to confirm the phenotype of isolated cells.
Can this method be applied to other tissues?
While specifically developed for aortic valves, some techniques may be adaptable to other tissues with similar structures.
What role does collagenase play in the process?
Collagenase is used to dissociate tissue and release cells without damaging them.
What is the significance of using human tissue samples?
Using human samples enhances the relevance of findings to human diseases as compared to animal models.
How does this research impact cardiovascular studies?
It provides foundational techniques for studying calcific aortic valve disease and aids in developing targeted therapies.
Executive Industry Relevance
Establishing patient-specific primary valve cell lines enables mechanistic de-risking in calcific aortic valve disease target validation. This workflow supports phenotypic screening and assay development using disease-relevant human cells, improving predictive confidence in early discovery. Access to control and CAVD cells facilitates translational biomarker identification and preclinical model refinement.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Interrogates therapeutic hypotheses by enabling direct comparison of control and diseased valve endothelial and interstitial cell phenotypes.
- Operational Value: Provides a reproducible human cell source for pathway clarification and osteogenic differentiation studies.
- Scientific Value: Supports functional target validation through immunostaining-confirmed expression of valve-specific markers.
Screening & Assay Development
- Scientific Value: Generates standardized primary cell preparations suitable for quantitative assessment of calcification via Von Kossa staining.
- Operational Value: Enables assay stabilization through cold storage solution use, maintaining approximately 40% cell viability up to 61 hours post-extraction.
- Operational Value: Yields spindle-shaped interstitial and cobblestone-like endothelial cells with consistent morphology for reliable compound screening.
Translational & Preclinical Research
- Scientific Value: Establishes disease-relevant systems by isolating cells from human calcific and control aortic valve tissues.
- Operational Value: Supports preclinical continuity by providing expanded cell lines for mechanical studies on disease onset and progression.
- Scientific Value: Facilitates biomarker alignment through confirmed phenotype-specific marker expression in isolated populations.
Pipeline & Workflow Integration
The method integrates into early discovery workflows by supplying validated human valve cells for hypothesis testing and pathway analysis in cardiovascular target programs.
- Discovery Biology: Enables interrogation of osteogenic transition mechanisms using primary human valve cells with confirmed endothelial and interstitial phenotypes.
- Screening: Delivers assay-ready cell populations stabilized by cold storage, supporting reproducible compound evaluation over multiple days.
- Analytics: Provides quantitative morphological and immunostaining readouts to compare control and disease cell responses.
- Translational Research: Connects discovery to preclinical validation through human-derived cells suitable for mechanical and calcification studies.
- Enterprise Reuse: Establishes a scalable primary cell isolation workflow applicable across multiple donor tissues for sustained R&D use.
Operational & Enterprise Impact
- Scientific Value: Increases target validation confidence by reducing mechanistic ambiguity in valve disease pathogenesis.
- Operational Value: Enhances reproducibility through standardized enzymatic dissociation and cold storage protocols.
- Strategic Value: Improves go/no-go decisions by enabling early phenotypic assessment of candidate targets in human valve cells.
- Portfolio Impact: Supports risk-adjusted prioritization via access to isogenic control and disease cell lines from patient samples.
Implementation Considerations
- Requires expertise in primary tissue handling and enzymatic cell dissociation techniques.
- Dependent on access to sterile tissue culture hoods, centrifuges, and collagenase preparation infrastructure.
- Necessitates cross-team standardization of tissue excision timing and cold storage solution application.
- Involves adaptation considerations for varying donor tissue quality and post-excision delay durations.
- Limited by the finite proliferative capacity of primary valve cells, requiring timely expansion and use.
Biopharma FAQs
Why does viability stabilization matter for target validation?
The cold storage solution maintains approximately 40% viability of valve endothelial and interstitial cells up to 61 hours post-extraction, enabling reliable downstream assays. This extended window supports consistent target engagement studies despite procurement delays. Stable viability ensures phenotypic fidelity during mechanistic investigations of calcific aortic valve disease.
How does collagenase concentration affect interstitial cell yield?
The protocol uses five to seven milliliters of cold collagenase solution to dissociate tissue and release valve interstitial cells from the dense extracellular matrix. Gentle rocking and repeated tissue swabbing optimize enzyme access without damaging cell membranes. This enzymatic step is essential for isolating the spindle-shaped interstitial population required for fibrosis and calcification studies.
What phenotypic markers confirm valve endothelial identity?
Expanded valve endothelial cells express expected tissue-specific markers validated by immunofluorescent staining, confirming cobblestone-like morphology and contact-inhibited growth. These markers establish endothelial lineage fidelity essential for studying endothelial-to-mesenchymal transition in disease. Phenotypic confirmation enables reliable use of these cells in angiogenesis and barrier function assays.
Why are replication requirements critical for cross-functional collaboration?
The protocol defines specific seeding densities—5 x 10⁵ cells/cm² for endothelial and 1.3 x 10⁴ cells/cm² for interstitial cells—to ensure reproducible monolayer formation across experiments. Standardized passaging at 80% confluence for endothelial and 90% confluence for interstitial cells supports consistent growth kinetics. These parameters enable assay comparability between discovery, screening, and preclinical teams.
What statistical analysis enables calcification assessment?
Von Kossa staining quantifies calcification through dark brown or black precipitation, providing a semi-quantitative readout for comparing control and diseased leaflet tissues. This output supports objective stratification of samples based on osteogenic differentiation extent. Quantitative image analysis of staining intensity can further enable dose-response modeling in therapeutic screening campaigns.
Chapters in this video
0:04
Introduction
0:34
Tissue Preparation and Processing
1:32
Valve Endothelial Cell (VEC) Isolation, Expansion, and Confirmation
4:01
Valve Interstitial Cell (VIC) Isolation, Expansion, and Confirmation
5:40
Results: Analysis of Isolated Human Primary Valve Cells
6:47
Conclusion
